Modification of adrenergic responses by antazoline and mepyramine.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001013:Aorta, Thoracic; D001794:Blood Pressure / Q000187:drug effects*; D004285:Dogs; D004336:Drug Antagonism; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology*; D005260:Female; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D007093:Imidazoles / Q000494:pharmacology*; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology*; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology*; D010413:Penis; D011817:Rabbits; D051381:Rats; D012669:Seminal Vesicles; D013270:Stomach; D014439:Tyramine / Q000494:pharmacology*
D000889:Anti-Arrhythmia Agents; D006634:Histamine H1 Antagonists; D007093:Imidazoles; D007545:Isoproterenol; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine